NASDAQ Biotechnology
NBI
4,679.38
27.43
0.00%
NASDAQ Biotechnology
The Nasdaq Biotechnology Index contains securities of Nasdaq-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The Nasdaq Biotechnology Index is calculated under a modified capitalization-weighted methodology.
The Index began on November 1, 1993 at a base value of 200.00.
Last | 4,679.38 |
Net Change | 27.43 |
Net Change(%) | 0.00% |
Day High | 4,693.07 |
Day Low | 4,651.85 |
Previous Close | 4,679.38 |
Base Value | 200.00 |
Divisor | 252,774,981 |
Name | Symbol | Sponsor |
---|---|---|
ProShares Ultra NASDAQ Biotechnology ETF | BIB | ProShares Trust |
ProShares UltraShort NASDAQ Biotechnology ETF | BIS | ProShares Trust |
Invesco Nasdaq Biotechnology ETF | IBBQ | Invesco |
Invesco NASDAQ Biotech UCITS ETF | SBIO | Invesco PowerShares |
Capital NASDAQ Biotechnology Index Exchang Traded Fund | 678 | Capital Securities Inv Tst Co. |
China Universal NASDAQ Biotechnology ETF QDII Fund | 513290 CH | China Universal Asset Management |
Mirae Asset TIGER Nasdaq BIO ETF | 203780 | Mirae Asset MAPS Global Investment Co., Ltd |
Name | Symbol | Sponsor |
---|---|---|
KSM ETF (4A) NASDAQ Biotechnology Currency Hedged | KSMF168 | KSM Mutual Funds Ltd |
TachSAL(4A) Comp S&PHealth(70%)NAS BIO(30%) Currency Hedged | TCHF53 | Meitav Tachlit Mutual Funds Ltd. |
Nasdaq Biotechnology Index Mother Fund | 04312181- | Daiwa Asset Management Co. Ltd. |
Tachlit SAL (4A) NASDAQ Biotechnology Currency-Hedged | TCHF142 | Meitav Tachlit Mutual Funds Ltd. |
Tachlit SAL (4D) NASDAQ Biotechnology | TCHF80 | Meitav Tachlit Mutual Funds Ltd. |